Distinct patterns of cytolytic T‐cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization

Cancer‐germline genes in both humans and mice have been shown to encode antigens susceptible to targeting by cytotoxic CD8 T effector cells (CTL). We analysed the ability of CTL to kill different tumour cell lines expressing the same cancer‐germline gene P1A (Trap1a). We previously demonstrated that CTL expressing a T‐cell receptor specific for the P1A35–43 peptide associated with H‐2Ld, although able to induce regression of P1A‐expressing P815 mastocytoma cells, were much less effective against P1A‐expressing melanoma cells. Here, we analysed parameters of the in vitro interaction between P1A‐specific CTL and mastocytoma or melanoma cells expressing similar levels of the P1A gene and of surface H‐2Ld. The mastocytoma cells were more sensitive to cytolysis than the melanoma cells in vitro. Analysis by video‐microscopy of early events required for target cell killing showed that similar patterns of increase in cytoplasmic Ca2+ concentration ([Ca2+]i) were induced by both types of P1A‐expressing tumour cells. However, the use of CTL expressing a fluorescent granzyme B (GZMB‐Tom) showed a delay in the migration of cytotoxic granules to the tumour interaction site, as well as a partially deficient GZMB‐Tom exocytosis in response to the melanoma cells. Among surface molecules possibly affecting tumour–CTL interactions, the mastocytoma cells were found to express intercellular adhesion molecule‐1, the ligand for LFA‐1, which was not detected on the melanoma cells.

[1]  H. Eisen,et al.  Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.

[2]  Fabian Kiessling,et al.  Vascular normalization in Rgs5-deficient tumours promotes immune destruction , 2008, Nature.

[3]  R. Koup,et al.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.

[4]  C. Drake,et al.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.

[5]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[6]  A. Rao,et al.  Calcium signaling in lymphocytes. , 2008, Current opinion in immunology.

[7]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[8]  D. Segal,et al.  Icam ‐ melanoma cells are relatively resistant to cd3‐mediated t‐cell lysis , 1990, International journal of cancer.

[9]  H. Fehling,et al.  Faithful activation of an extra‐bright red fluorescent protein in “knock‐in” Cre‐reporter mice ideally suited for lineage tracing studies , 2007, European journal of immunology.

[10]  Michael Loran Dustin,et al.  Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Boyer,et al.  Visualization of Cytolytic T Cell Differentiation and Granule Exocytosis with T Cells from Mice Expressing Active Fluorescent Granzyme B , 2013, PloS one.

[12]  I. Huijbers,et al.  Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice. , 2010, Cancer research.

[13]  H. Pircher,et al.  A Critical Requirement of Interferon γ-mediated Angiostasis for Tumor Rejection by CD8+ T Cells , 2003 .

[14]  James C. Whisstock,et al.  Perforin and granzymes: function, dysfunction and human pathology , 2015, Nature Reviews Immunology.

[15]  M. Buferne,et al.  Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells? , 2013, Pigment cell & melanoma research.

[16]  I. Huijbers,et al.  Minimal Tolerance to a Tumor Antigen Encoded by a Cancer-Germline Gene , 2012, The Journal of Immunology.

[17]  L. Leserman,et al.  Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma. , 2012, Cancer research.

[18]  A. Tsun,et al.  The Strength of T Cell Receptor Signal Controls the Polarization of Cytotoxic Machinery to the Immunological Synapse , 2009, Immunity.

[19]  S. Spicuglia,et al.  Active STAT5 Regulates T-bet and Eomesodermin Expression in CD8 T Cells and Imprints a T-bet–Dependent Tc1 Program with Repressed IL-6/TGF-β1 Signaling , 2013, The Journal of Immunology.

[20]  G. Griffiths,et al.  Secretory mechanisms in cell-mediated cytotoxicity. , 2007, Annual review of cell and developmental biology.

[21]  S. Jameson,et al.  The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. , 2001, Immunity.

[22]  Clemens Utzny,et al.  Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: Manifestation of a dual activation threshold , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Hai-Tao He,et al.  Barcoding T Cell Calcium Response Diversity with Methods for Automated and Accurate Analysis of Cell Signals (MAAACS) , 2013, PLoS Comput. Biol..

[24]  A. Lanzavecchia,et al.  Serial triggering of many T-cell receptors by a few peptide–MHC complexes , 1995, Nature.

[25]  M. Mescher,et al.  ICAM‐1 and B7‐1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM‐1 , 1999, European journal of immunology.

[26]  S. Rosenberg,et al.  Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. , 2005, The Journal of clinical investigation.

[27]  C. Robert,et al.  ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway. , 2008, Cancer research.

[28]  Arup K Chakraborty,et al.  Understanding the Structure and Function of the Immunological Synapse , 2010 .

[29]  C. Nguyen,et al.  CD8 T Cell Help for Innate Antitumor Immunity1 , 2007, The Journal of Immunology.

[30]  Roxana Khazen,et al.  Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse , 2016, Nature Communications.

[31]  C. Nguyen,et al.  CD 8 T Cell Help for Innate Antitumor Immunity 1 , 2007 .

[32]  R Y Tsien,et al.  Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets. , 1987, The EMBO journal.

[33]  P. Coulie,et al.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy , 2014, Nature Reviews Cancer.

[34]  R. Penner,et al.  STIM2 drives Ca2+ oscillations through store‐operated Ca2+ entry caused by mild store depletion , 2013, The Journal of physiology.

[35]  I. Hwang,et al.  LFA-1-dependent Ca2+ Entry following Suboptimal T Cell Receptor Triggering Proceeds without Mobilization of Intracellular Ca2+* , 2009, The Journal of Biological Chemistry.

[36]  I. Caramalho,et al.  Visualizing CTL/melanoma cell interactions: multiple hits must be delivered for tumour cell annihilation , 2008, Journal of cellular and molecular medicine.

[37]  S. H. van der Burg,et al.  Anti–CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response , 2014, Science Translational Medicine.

[38]  Thomas M. Schmitt,et al.  T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma. , 2015, Cancer cell.

[39]  A. Schmitt‐Verhulst,et al.  Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T‐cell receptor diversity , 2010, Immunology.

[40]  A. Fischer,et al.  Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules , 2010, Nature Reviews Immunology.

[41]  K. Schwarz,et al.  ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis , 2011, Proceedings of the National Academy of Sciences.

[42]  Jérôme Galon,et al.  The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. , 2013, Immunity.

[43]  A. Cooke Infection and autoimmunity. , 2009, Blood cells, molecules & diseases.

[44]  S. Feske,et al.  Regulation of lymphocyte function by ORAI and STIM proteins in infection and autoimmunity , 2012, The Journal of physiology.

[45]  J. Lieberman,et al.  Perforin pores in the endosomal membrane trigger release of endocytosed granzyme B to the cytosol of target cells , 2011, Nature Immunology.

[46]  R. Emerson,et al.  PD-1 blockade induces responses by inhibiting adaptive immune resistance , 2014, Nature.

[47]  M. Hoth,et al.  Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells. , 2013, Biochimica et biophysica acta.

[48]  L. Leserman,et al.  IFNγ producing CD8+ T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas , 2015, Oncoimmunology.

[49]  T. Mak,et al.  Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. , 1997, Immunity.

[50]  M. Davis,et al.  Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. de Waal Malefyt,et al.  CD2/LFA‐3 or LFA‐l/ICAM‐1 but not CD28/B7 interactions can augment cytotoxicity by virus‐specific CD8+ cytotoxic T lymphocytes , 1993, European journal of immunology.

[52]  I. Huijbers,et al.  An inducible mouse model of melanoma expressing a defined tumor antigen. , 2006, Cancer research.

[53]  R. Flavell,et al.  Emerging Roles of L-Type Voltage-Gated and Other Calcium Channels in T Lymphocytes , 2013, Front. Immunol..

[54]  Bin Zhang,et al.  IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers. , 2008, The Journal of clinical investigation.

[55]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[56]  P. Chomez,et al.  Thymocyte-Intrinsic Genetic Factors Influence CD8 T Cell Lineage Commitment and Affect Selection of a Tumor-Reactive TCR1 , 2004, The Journal of Immunology.

[57]  Weiyang Jin,et al.  Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing , 2016, Cell.

[58]  Michael W. Davidson,et al.  Actin Depletion Initiates Events Leading to Granule Secretion at the Immunological Synapse , 2015, Immunity.

[59]  W. Jefferies,et al.  Tweeters, Woofers and Horns: The Complex Orchestration of Calcium Currents in T Lymphocytes , 2015, Front. Immunol..

[60]  D. Morgan,et al.  The Role of Intercellular Adhesion Molecule-1/LFA-1 Interactions in the Generation of Tumor-Specific CD8+ T Cell Responses1 , 2005, The Journal of Immunology.

[61]  David Kotlyar CD8 T Cells , 2016 .

[62]  C. Nguyen,et al.  STAT5-Mediated Signals Sustain a TCR-Initiated Gene Expression Program toward Differentiation of CD8 T Cell Effectors1 , 2006, The Journal of Immunology.

[63]  R. Flavell,et al.  Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis , 2009, Proceedings of the National Academy of Sciences.

[64]  C. Uyttenhove,et al.  Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression , 1983, The Journal of experimental medicine.

[65]  R. Holcombe,et al.  Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. , 1996, Cellular immunology.

[66]  C. Uyttenhove,et al.  The shared tumor‐specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection , 1998, European journal of immunology.